Seres Therapeutics Inc (MCRB)

07:04 AM

Seres Therapeutics announces leadership transition - MSN

07:04 AM

06:05 AM

Seres Therapeutics Soars 10.98% on Leadership Transition - AInvest

06:05 AM

02:28 AM

What drives Seres Therapeutics Inc. stock priceExtraordinary profit generation - Autocar Professional

02:28 AM

Jul 22, 2025

Seres Therapeutics Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Seres Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics stock jumps after naming co-CEOs By Investing.com - Investing.com Canada

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics (MCRB) Announces Transition in Executive Lead - GuruFocus

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics Announces Leadership Transition - The Manila Times

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025 - The Manila Times

Jul 22, 2025

Jul 22, 2025

Seres Therapeutics to Host Conference Call on August 6, 2025, to Discuss Q2 Financial Results and Business Updates - Quiver Quantitative

Jul 22, 2025

Jul 21, 2025

Seres Therapeutics, Inc.'s (NASDAQ:MCRB) top owners are individual investors with 51% stake, while 23% is held by institutions - Yahoo Finance

Jul 21, 2025

Jul 20, 2025

individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week - simplywall.st

Jul 20, 2025

Jul 19, 2025

What analysts say about Seres Therapeutics Inc. stockDynamic investment opportunities - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

what makes seres therapeutics inc. stock price move sharplyChart Breakout Alert - Newser

Jul 18, 2025

Jul 18, 2025

How high can Seres Therapeutics Inc. stock price go in 2025Protected Capital Trading Plan - Newser

Jul 18, 2025

Jul 15, 2025

What makes Seres Therapeutics Inc. stock price move sharplyFree Trading Group - Newser

Jul 15, 2025

Jul 15, 2025

How Seres Therapeutics Inc. stock performs during market volatilityWatchlist Winner Update - Newser

Jul 15, 2025

Jul 15, 2025

Why Seres Therapeutics Inc. stock attracts strong analyst attentionFree Smart Money Group - Newser

Jul 15, 2025

Jul 14, 2025

Seres Therapeutics Soars 21%—What’s Fueling the Biotech Breakout? - AInvest

Jul 14, 2025

Jul 01, 2025

5 Best Microbiome Companies (July 2025) - Securities.io

Jul 01, 2025

Jun 30, 2025

Seres Therapeutics, Inc.(NasdaqGS: MCRB) added to Russell 3000E Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

Seres Therapeutics, Inc.(NasdaqGS: MCRB) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025

Jun 25, 2025

Seres Therapeutics May 2025 slides: SER-155 shows 77% infection reduction in transplant patients - Investing.com

Jun 25, 2025

Jun 12, 2025

FMR LLC Reduces Stake in Seres Therapeutics Inc: A Strategic Rea - GuruFocus

Jun 12, 2025

Jun 02, 2025

Denodo University Challenge Now Open: Data and AI for Real-World Impact - GlobeNewswire Inc.

Jun 02, 2025

May 28, 2025

Seres Therapeutics, Inc. (NASDAQ:MCRB) Given Consensus Recommendation of “Reduce” by Brokerages - Defense World

May 28, 2025

May 27, 2025

Seres Therapeutics reports promising biomarker data By Investing.com - Investing.com South Africa

May 27, 2025

May 27, 2025

Seres Therapeutics (MCRB) to Present New Biomarker Data at ASCO 2025 | MCRB Stock News - GuruFocus

May 27, 2025

May 27, 2025

Seres Therapeutics reports promising biomarker data - Investing.com

May 27, 2025

May 27, 2025

Seres Therapeutics to Present New Biomarker Data from SER-155 Phase 1b Study at 2025 ASCO Annual Meeting - Nasdaq

May 27, 2025

May 27, 2025

Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting - The Manila Times

May 27, 2025

May 27, 2025

Breakthrough: Seres Therapy Cuts Deadly Infection Risk by 77% in Cancer Transplant Patients, ASCO Data Shows - Stock Titan

May 27, 2025

May 23, 2025

Seres Therapeutics (MCRB) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

May 23, 2025

May 17, 2025

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below Two Hundred Day Moving Average – Here’s Why - Defense World

May 17, 2025

May 16, 2025

Wall Street Analysts Believe Seres Therapeutics (MCRB) Could Rally 713.09%: Here's is How to Trade - NewsBreak: Local News & Alerts

May 16, 2025

May 12, 2025

Human Microbiome Market Forecast: Growth Trends, Key Players & - openPR.com

May 12, 2025

May 11, 2025

Seres Therapeutics’ (MCRB) “Neutral” Rating Reiterated at Chardan Capital - Defense World

May 11, 2025